Cong Xu
Private Equity Investor at LAV Management Co., Ltd.
Profile
Cong Xu is currently the Managing Director at LAV Management Co., Ltd.
He previously worked as the Vice President at IMPACT Therapeutics, Inc. from 2018 to 2019.
Mr. Xu graduated from Clemson University in 2012 with a graduate degree and obtained an MBA from the University of British Columbia in 2018.
Cong Xu active positions
| Companies | Position | Start |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 2017-12-31 |
Former positions of Cong Xu
| Companies | Position | End |
|---|---|---|
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | President | 2019-11-30 |
Training of Cong Xu
| Clemson University | Graduate Degree |
| University of British Columbia | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |
- Stock Market
- Insiders
- Cong Xu
